BSX vs LHX · P/E 20, rev $20.07B vs P/E 34, rev $5.88B
Boston Scientific Corp (BSX) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the BSX and LHX stock pages for the full models.
Not investment advice.